HALOZYME THERAPEUTICS, INC.

Licenses a drug delivery platform to biopharma, converting IV drugs to subcutaneous injections.

HALO | NDAQ

Overview

Corporate Details

ISIN(s):: US40637H1095
LEI:
Country:: United States of America
Address:: 12390 EL CAMINO REAL, 92130 SAN DIEGO
Website:: https://www.halozyme.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Halozyme Therapeutics, Inc. is a biotechnology company focused on its proprietary drug delivery technology platform, ENHANZE®. This technology facilitates the subcutaneous (under-the-skin) delivery of injectable drugs and biologics that are often administered intravenously. Halozyme licenses its ENHANZE® technology to global biopharmaceutical companies, enabling them to develop new formulations of their therapies. This model aims to reinvent the patient experience by reducing treatment burden and shortening administration times, particularly in therapeutic areas such as oncology. The company's commercial portfolio is primarily built on royalties and milestone payments derived from its partners' sales of products utilizing the ENHANZE® platform.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all HALOZYME THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HALOZYME THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for HALOZYME THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
TRAJANO Provides strategic consulting and innovative business solutions.	Spain	YTRA
Transgene Developing viral immunotherapies like vaccines and oncolytic viruses to treat solid tumors.	France	TNG
TRANS GENIC GROUP INC. Offers drug discovery CRO services (gene editing, trials) and business investment/consulting.	Japan	2342
Trevi Therapeutics, Inc. Clinical-stage biopharma developing an oral therapy for chronic cough in IPF and RCC.	United States of America	TRVI
TrueBlue, Inc. Provides staffing, recruitment, and workforce solutions for businesses in diverse sectors.	United States of America	TBI
True Data Inc. A big data platform offering consumer purchasing analytics from Japan's largest ID-POS data network.	Japan	4416
Tsubota Laboratory Incorporated Developing pharmaceuticals and medical devices for ophthalmic and brain diseases.	Japan	4890
TWOSTONE&Sons Inc. An engineer platform providing IT talent and marketing services for corporate digital transformation.	Japan	7352
UJU Holding Limited AI-driven, full-link short-video marketing solutions for enterprises in China.	Hong Kong	1948
unerry,Inc. Transforms location data into actionable insights for retail and public sectors using AI.	Japan	5034